Thyroid hormones affect serum angiotensin I converting enzyme levels

Area of Science:

• Endocrinology
• Immunology
• Biochemistry

Background:

• Thyroid dysfunction, including Graves' disease and thyroiditis, significantly impacts metabolic processes.
• Angiotensin I converting enzyme (ACE) plays a role in cardiovascular and immune functions.
• Understanding ACE regulation in thyroid disease is crucial for patient management.

Purpose of the Study:

• To investigate the relationship between serum ACE levels and thyroid function in patients with Graves' disease and thyroiditis.
• To evaluate the effect of thyroxine treatment on serum ACE levels in thyroid cancer patients.
• To explore the quantitative nature of ACE level changes during thyroid hyperfunction.

Main Methods:

• Serum ACE levels were measured in patients with Graves' disease, thyroiditis, and thyroid cancer.
• Enzyme kinetic and inhibitor binding assays were employed for ACE quantification.
• Thyroid function and hormone levels were clinically assessed and correlated with ACE measurements.

Main Results:

• Serum ACE levels showed a positive correlation with thyroid function and peripheral hormone levels, particularly during hyper- or hypothyroid states.
• ACE increments during thyroid hyperfunction were confirmed as quantitative, not due to increased enzyme activity.
• No correlation was found between serum ACE and lysozyme, suggesting distinct regulatory mechanisms.

Conclusions:

• Serum ACE levels serve as a potential biomarker for assessing thyroid function.
• ACE measurements can aid in monitoring the efficacy of thyroxine treatment.
• Further research is warranted to elucidate the precise mechanisms of ACE regulation in thyroid disorders.